Clinical trial
Construction of an Assessment Model for Vitiligo Disease Activity and Treatment Prognosis Based on Peripheral Blood Cytokine Profiles
NCT07298551 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Construction of an Assessment Model for Vitiligo Disease Activity and Treatment Prognosis Based on Peripheral Blood Cytokine Profiles
- Lead sponsor
- Xijing Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- December 23, 2025
- Completion date
- September 1, 2027
- Enrollment
- 125 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.